Selective prostate cancer thermal ablation with laser activated gold nanoshells

Journal of Urology

Volumn 179, Issue 2, 2008, Pages 748-753

  Stern, Joshua M ^a   Stanfield, Jennifer ^a   Kabbani, Wareef ^b   Hsieh, Jer Tsong ^a   Cadeddu, Jeffrey A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Gold; Lasers; Mice, nude; Prostate; Prostatic neoplasms

Indexed keywords

CYTOCHROME B5 REDUCTASE; EOSIN; GOLD NANOPARTICLE; HEMATOXYLIN; GOLD; METAL NANOPARTICLE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH TEMPERATURE; HUMAN; HUMAN CELL; INFRARED RADIATION; LOW LEVEL LASER THERAPY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; STAINING; TEMPERATURE; TUMOR MODEL; TUMOR NECROSIS; TUMOR REGRESSION; TUMOR VOLUME; ANIMAL; DISEASE MODEL; ELECTROCOAGULATION; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROCOAGULATION; GOLD; LASER THERAPY; MALE; METAL NANOPARTICLES; MICE; MICE, NUDE; PROSTATIC NEOPLASMS;

EID: 38849155323     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.09.018     Document Type: Article

References (20)

1. Carroll PR, Presti JC Jr, Small E and Roach M: Focal therapy for prostate cancer 1996: maximizing outcome Urology 1997;49:84.
2. Akduman B, Barqawi AB and Crawford ED: Minimally invasive surgery in prostate cancer: current and future perspectives. Cancer J 2005;11:355.
3. Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T et al: Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006;13:228.
4. Hacker A, Kohrmann KU, Back W, Kraut O, Marlinghaus E, Alken P et al: Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int 2005;96:71.
5. Beerlage HP, Thuroff S, Debruyne FM, Chaussy C and de la Rosette JJ: Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 1999;54:273.
6. Loo C, Lowery A, Halas N, West J and Drezek R: Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005;5:709.
7. Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ et al: Metal nanoshells. Ann Biomed Eng 2006;34:15.
8. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE et al: Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003;100:13549.
9. O'Neal DP, Hirsch LR, Halas NJ, Payne JD and West JL: Photo-thermal tumor ablation in mice using near infraredabsorbing nanoparticles Cancer Lett 2004;209:171.
10. Stern JM, Anderson JK, Lotan Y, Park S and Cadeddu JA: Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol 2006;176:1969.
11. Litzinger DC, Buiting AM, van Rooijen N and Huang L: Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly (ethylene glycol) -containing liposomes Biochim Biophys Acta 1994;1190:99.
12. Stern JM, Stanfield J, Lotan Y, Park S, Hsieh JT and Cadeddu JA: The efficacy of laser activated gold nanoshells to ablate prostate cancer cells in vitro. J Endourol 2007;21:939.
13. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D and Jain RK: Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 1994;54:3352.
14. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D et al: Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000;60:6950.
15. Kong G, Braun RD and Dewhirst MW: Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000;60:4440.
16. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M et al: Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 1996;36:55.
17. Gao X, Cui Y, Levenson RM, Chung LW and Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22:969.
18. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW et al: Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 2006;103:6315.
19. Patriarca C, Bergamaschi F, Gazzano G, Corrada P, Ordesi G, Zanitzer L et al: Histopathological findings after radiofrequency (RITA) treatment for prostate cancer. Prostate Cancer Prostatic Dis 2006;9:266.
20. Mambula SS and Calderwood SK: Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia 2006;22:575.